This resource provides a summary of AURA 2021 data that may be of specific interest to medical practitioners.
This resource provides a summary of AURA 2021 data that may be of specific interest to hospital and community pharmacists.
This report provides supplementary data relevant to Chapter 4 of AURA 2021 - Antimicrobial resistance.
This report includes analyses of antimicrobial resistance and antimicrobial use data predominantly collected in 2018 and 2019, and 2020 data from the National Alert System for Critical Antimicrobial Resistances (CARAlert) the Pharmaceutical Benefits Scheme (PBS) in the context of the COVID-19 pandemic.
The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System collects, reviews and analyses data on antimicrobial use and antimicrobial resistance in human health.
This issue includes items on COVID-19, medication safety, community pharmacy, paediatric mediation errors, mental health, healthcare associated infections and more.
Also covered are the latest issues of the Australian Journal of Primary Health Review, Patient Experience Journal and Pediatric Quality & Safety along with the latest online papers from BMJ Quality & Safety and International Journal for Quality in Health Care and the latest from the UK’s NICE and the USA’s AHRQ.
Assessment to the national pathology accreditation standards
National Association of Testing Authorities, Australia (NATA)
Resources to support clinicians, service providers and accrediting agencies. Guidance on the requirements for pathology laboratories to be accredited.
Overview
The pathology accreditation standards used in Australia protect the public from harm and ensure consistency in pathology practice.